Gene Query: ALDH3B1

Dataset Description Geneva Score
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 143.74
Gene expression analysis of the impact of TDP-43 knockout in human cells. 108.39
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 74.16
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 52.95
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 51.71
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 46.46
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 44.55
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 42.93
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 39.88
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 39.88
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 37.98
Ebola virus (EBOV) infection of ARPE-19 cells 37.55
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 36.45
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 35.32
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 35.32
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 34.73
Effect of Influenza virus infection on lncRNA expression in A549 cells 33.19
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 32.61
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 32.16
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 32.16
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 31.76
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 30.97
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 30.48
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 30.48
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 29.4
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 29.04
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 28.71
Tumor exosome integrins determine organotropic metastasis 28.32
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 28.25
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 27.8
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 27.36
Nrf2 regulated genes in A549 cells 27.0
Identification of Nrf2 regulated genes by RNA sequencing 27.0
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 26.15
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 25.78
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 25.53
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 25.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 25.02
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 24.96
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 24.84
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 24.1
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 23.65
Transcriptomic analysis of the HOTAIR-regulated genes 23.18
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 23.08
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 22.77
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 22.75
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 22.71
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 22.7
ARS2 is a general suppressor of pervasive transcription [RNAseq] 22.65
TGF-β promotes genomic instability after loss of RUNX3 22.39
NHLRC1 re-expression in cancer cells 22.34
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 22.34
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 22.2
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 21.95
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 21.86
IL-33 activates tumor stroma to promote intestinal polyposis 21.71
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 21.21
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 21.21
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 21.2
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 21.2
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 21.14
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 21.01
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 20.95
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 20.95
FOXD3 is a novel tumor suppressor in lung cancer 20.89
Genome wide expression change by RNF168 knocking down in NEC cells 20.84
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 20.83
Region-specific Innate Antiviral Responses of the Human Epididymis 20.6
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 20.49
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 20.49
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 20.25
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 19.67
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 19.28
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 19.06
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 19.06
Nonpregnant and term pregnant human myometrial tissues 18.91
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 18.91
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 18.77
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 18.77
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 18.66
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 18.31
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 18.14
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 17.99
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 17.96
Differential Gene Expression between MCF10A and MCF7 cells 17.96
METTL3 promotes translation in human cancer cells 17.92
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 17.8
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 17.71
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 17.7
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 17.59
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 17.54
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 17.47
CircRNAome diversity in human mature B-cells, T-cells and monocytes 17.23
TFAP2C signalling in human fibroblasts 17.13
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 17.08
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 16.99
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 16.95
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 16.95
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 16.68
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 16.63
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 16.53
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 16.26
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 16.26
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 16.26
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 16.22
RNA seq analysis of human Fetal and adult derived Enterospheres 16.2
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 16.2
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 15.95
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 15.56
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 15.56
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 15.47
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 15.11
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 15.06
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 15.06
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.94
Accurate annotation of human protein-coding small open reading frames 14.76
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 14.57
Role of CD133 molecule in WNT response and renal repair 14.47
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 14.46
Comparing gene expression in iPSC derived RPE from control and AMD donors 14.4
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 14.4
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 14.27
Survival of pancreatic cancer cells lacking KRAS function 14.24
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 14.22
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 14.22
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 14.13
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 14.11
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 14.1
Spliceosomal disruption of the non-canonical BAF complex in cancer 14.0
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 13.64
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.58
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.58
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 13.34
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 13.23
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 13.2
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 12.97
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 12.88
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 12.85
The role of the Calcium-Sensing receptor in colorectal cancer 12.83
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 12.71
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 12.62
Mutational landscape of splicing genes and functional consequences across 33 cancer types 12.6
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  12.59
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 12.53
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 12.53
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 12.41
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 12.33
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 12.33
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 12.31
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 12.31
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 12.3
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 12.23
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 12.15
CD86 regulates a pro-survival signal in myeloma cells 12.14
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 12.11
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 12.06
Targeting MTHFD2 in Acute Myeloid Leukemia 11.94
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 11.89
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 11.86
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 11.79
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.77
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 11.77
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 11.74
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 11.68
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.67
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.67
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 11.52
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 11.48
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 11.42
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 11.36
snRNAs as regulators of alternative splicing 11.31
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 11.31
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 11.31
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 11.31
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 11.22
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 11.19
High-efficiency RNA-based reprogramming of human primary fibroblasts 11.18
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 11.16
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 11.14
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 10.98
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.98
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 10.97
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 10.94
H1609088 Human RNA-Sequencing 10.92
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.9
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 10.87
Gene expression in GBM with Cav3.2 inhibition 10.82
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 10.73
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 10.73
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 10.7
Transcriptome of U251 cells overexpression complement component 7 10.69
Differentially expressed genes post knock down of lincDUSP26 10.68
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 10.66
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 10.66
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 10.65
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 10.61
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 10.52
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 10.51
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 10.39
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 10.38
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 10.38
RNA-seq analysis of control and Myc-induced U2OS cells 10.37
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 10.33
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 10.25
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 10.14
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.12
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 10.11
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 10.07
mRNA differential expression analysis in a human ex vivo model of chronic wounds 10.02
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 9.99
TAF1 is critical for AE driven leukemogenesis 9.99
MicroRNA targetome analysis during HCMV infection 9.95
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 9.94
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 9.89
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 9.83
RNA-seq of MCF10A cells and CAF 9.75
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 9.69
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 9.67
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 9.66
LIN28A modulates splicing and gene expression programs in breast cancer cells 9.66
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 9.63
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.59
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.59
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 9.59
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 9.41
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 9.41
Finding missing proteins from epigenetically manipulated human cells 9.39
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 9.35
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 9.35
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.32
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 9.32
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 9.29
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 9.23
The cohesin complex prevents Myc-induced replication stress 9.21
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 9.18
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 9.15
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 9.15
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 9.1
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 8.96
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 8.95
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.94
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 8.88
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 8.88
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 8.69
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  8.62
Nutritional control of protein translation 8.6
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 8.58
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 8.56
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 8.53
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.42
Small-molecule targeting of brachyury transcription factor addiction in chordoma 8.4
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.39
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 8.3
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.3
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 8.22
IDH3a KO RNA-seq 8.16
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.16
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.05
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 8.01
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.99
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.99
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 7.96
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 7.94
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 7.94
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 7.94
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.92
Transcriptome profiling of 5 human adenocarcinoma cell lines 7.9
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 7.89
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 7.83
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 7.82
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 7.82
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.8
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 7.79
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 7.78
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 7.76
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 7.75
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.66
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.65
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.64
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.64
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.62
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.59
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 7.53
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 7.53
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.53
Impact on erythroid progenitor type on erythroid differntiation 7.49
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 7.47
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 7.45
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 7.41
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 7.4
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 7.26
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 7.25
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 7.13
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 7.11
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 7.05
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 7.05
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 7.05
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 7.02
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 7.0
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.0
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.0
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 6.99
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 6.98
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 6.95
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 6.94
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 6.94
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.93
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.85
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.71
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 6.71
A sister of NANOG regulates genes expressed in pre-implantation human development 6.7
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 6.68
IRF1 regulates IFN dependent and independent gene expression 6.67
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 6.67
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 6.63
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.62
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 6.62
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 6.6
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 6.54
High level DNA repair gene expression in human ES cells 6.5
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 6.36
LIN28A Over-expression RNAseq 6.31
Regulation of poly(A) tail and translation during the somatic cell cycle 6.27
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 6.25
Transcriptomic analysis of LSD1 6.21
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 6.19
HEXIM1 is induced by DHODH inhibition to suppress melanoma 6.19
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 6.15
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.11
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 6.04
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 6.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 5.98
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 5.96
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.9
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.9
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 5.88
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.86
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 5.86
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.84
Transciptomic profiling of human fetal lung samples 5.81
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.78
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 5.74
Regulation of highly expressed hCINAP on translatome 5.74
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 5.64
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 5.63
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.59
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.57
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 5.48
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.47
Overexpression and knockdown experiment for circCSNK1G3 5.43
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.4
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.4
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.36
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.25
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 5.24
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 5.24
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 5.21
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 5.13
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 5.09
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 5.08
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 5.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.07
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.05
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 5.05
NAPRT activation of macrophages 4.99
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.98
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.86
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.84
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 4.74
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 4.73
Gene expression of thyroid cancer cell lines 4.69
RNA-seq of MDA-MB-231 cells with TET1 knockout 4.65
Transcriptome analysis of human lung epithelial cells 4.64
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.63
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 4.6
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.59
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 4.57
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 4.48
Dysregulated immune system networks in war veterans with PTSD 4.41
Transcriptome-wide modulation of splicing by the exon junction complex 4.4
Transcriptional profile in human S. haematobium infection 4.38
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.32
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.11
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 4.01
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 4.0
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 4.0
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 3.92
Gene expression analysis in response to hypoxic pathway inhibition 3.91
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 3.9
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.81
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.81
CSL 3.7
CSL RNA-Seq on HKC and SCC cell lines 3.7
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.6
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.41
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.33
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 3.3
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 3.29
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 3.26
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 3.2
mRNA sequencing of oropharyngeal cancer cell lines 3.11
Gene expression analysis of human liver progenitor-like cells in culture 3.07
Efficient derivation of microglia-like cells from human pluripotent stem cells 3.02
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.95
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.85
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.79
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.76
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.66
Trascriptome of thyroid cancer-induced macrophages 2.65
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.62
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.55
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.52
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 2.39
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.35
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.35
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.34
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.34
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 2.31
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.3
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 2.26
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.23
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.22
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.18
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.16
DRB/GRO-Seq -/+ UV 2.15
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.02
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.01
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.96
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.96
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.95
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.95
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.91
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.88
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 1.83
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.81
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.81
Identification of renal resident macrophages across species [C1] 1.81
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.79
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.78
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.77
Metabolism as an early predictor of DPSCs aging 1.75
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.63
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.63
UV_24h_GRO-Seq 1.5
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.47
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.47
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 1.46
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.43
Transcriptome analysis reveals differential splicing events in IPF lung tissue 1.42
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.42
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.41
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.4
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.38
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.36
A map of gene expression in neutrophil-like cell lines 1.36
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.36
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.36
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.32
circRNA-sequencing 1.31
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.27
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.19
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.13
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.12
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.12
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.05
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.01
Genome-wide discovery of human splicing branchpoints [RNAse] 1.0
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.98
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.93
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.92
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.92
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.82
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.77
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.74
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.72
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.72
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.72
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.71
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.66
BMS-470539 on human synovial fibroblasts 0.62
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.6
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.56
Transcriptome analysis in Neobractatin treated cells 0.48
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.37
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.34
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.34
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.33
RNA sequencing of human pancreatic cancer cell lines 0.32
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.32
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.31
Specific molecular signatures underlie response to decitabine in CMML 0.31
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.28
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.25
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.24
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.13
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.08
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.04
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.04
Gene expression changes due to PARP knockdown in human cells 0.04
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation